by Richard Daverman, PhD
September 13, 2103 -- BGI Tech Solutions Co., a subsidiary of the world’s largest genomics research organization, BGI, will collaborate with the South Texas Accelerated Research Therapeutics (START) on a cancer genome study. The study, the San Antonio 1000 Cancer Genome Project, will be the first to link cancer-related genetic alterations with their clinical outcomes. BGI and START expect their findings to help scientists discover targeted, personalized cancer treatments. More details....
Help employers find you! Check out all the jobs and post your resume.
